Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 1 7Phase 2 4Phase 2/3 2Phase 1/2 2Phase NA 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Extravasation 1Anthracycline Extravasation 1

Interventions

Cisplatin 22Fluorouracil 21Radiotherapy 18Gemcitabine 17Docetaxel 16Oxaliplatin 15Paclitaxel 14Carboplatin 13Capecitabine 13Bevacizumab 13Leucovorin 11Cyclophosphamide 11Irinotecan 10Drug Therapy 10Cytarabine 9Saline Solution 7Magnetic Resonance Spectroscopy 7Letrozole 7Dexamethasone 7Rituximab 6Nivolumab 6Methotrexate 6Exercise 6Etoposide 6Electroporation 6Doxorubicin 6pembrolizumab 5Pemetrexed 5Metformin 5Melphalan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Completed × Dexrazoxane × Clear all
NCT00548561 2015-10-21

Efficacy of TopotectTM (Dexrazoxane) for Accidental Extravasation of Anthracyclines

Valerio Therapeutics

Phase 2/3 Completed
23 enrolled

Anthracycline Extravasation

NCT00548704 2015-10-21

A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines

Valerio Therapeutics

Phase 2/3 Completed
57 enrolled

Extravasation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡